IAC Pre-Congress One day Tutorial

Dr. Bongiovanni is head of Cytopathology at SYNLAB Pathology in Lausanne, Switzerland.

He is member of the Pathology Expert Group, at SYNLAB International, Member (MIAC) and then Fellow (FIAC) of the International Academy of Cytology since 2016.

Dr Bongiovanni completed his medical studies in 1997 and his residency in Pathology in 2002 at the University of Turin in Italy. In 2003, he joined the Institute of Pathology at the University Hospital of Geneva (HUG), where he began his scientific and clinical work in the field of pathology and cytopathology. After gaining experience in Ticino as deputy director of the Cantonal Institute of Pathology (2010-2014), he was appointed as associate professor and head of the Department of Cytopathology at the Institute of Pathology of the University Hospital of Lausanne (CHUV, 2014).

He is the author of more than 200 scientific articles and 15 book chapters. He was Vice President of the Swiss Cytology Society (2015-2021) and member of the Endocrine Tumor Group of the European Organisation for Research and Treatment of Cancer (EORTC). He is associate editor of the journal Acta Cytologica and participates in the editorial board of the journal Diagnostic Cytopathology. He is currently co-chair of the scientific committee of the European Federation of Cytology Societies (EFCS).

Dr. Baloch received his medical degree from Liaquat Medical University in Sind, Pakistan. After receiving his PhD in 1991 he joined the pathology residency at Hahnemann University Hospital. This was followed by fellowships in surgical pathology at Memorial Sloan Kettering Cancer Center, New York and cytopathology at the University of Pennsylvania Medical Center, Philadelphia. Dr. Baloch began his career as an assistant professor in the Department of Pathology & Laboratory Medicine at UPENN medical center in1997 and is currently a professor of pathology and laboratory medicine there. He has authored more than 200 peer reviewed publications in leading pathology journals on the subject of endocrine and head and neck pathology; and book chapters and monographs. Dr. Baloch has delivered numerous lectures, workshops and short courses both at the national and international meetings including ASC, USCAP, ASCP, CAP, ECC and IAP. Dr. Baloch has co-authored 3 books and has served as co-editor of the most recent Milan System for Reporting Salivary Gland Cytopathology. Dr. Baloch has also served as the chair of the terminology and morphologic criteria committee of the 2007 NCI sponsored thyroid FNA initiative which led to the development of ?Bethesda Thyroid FNA Classification Scheme?. Dr. Baloch also served on the international panel which recommended the renaming of encapsulated follicular variant of papillary thyroid carcinoma to non-invasive follicular tumor with papillary like nuclear features (NIFTP). Dr. Baloch is executive editor of Diagnostic Cytopathology and member of the editorial board of Cancer Cytopathology, Cytojournal, Endocrine Pathology and Journal of American Society of Cytopathology.

Dr. Baloch has served as the chair of ASCP and ASC annual meeting scientific program committee, member of USCAP education committee, ASC executive board, ASCP committee for continuing professional development, Papanicolaou Society scientific program committee, American Association of Endocrinologist thyroid nodule guideline task force and American Thyroid Association laboratory test committee.

Prof Tse is a chairman and professor in the Department of Anatomical and Cellular Pathology, Prince of Wales Hospital and the Chinese University of Hong Kong. He is the president of the Hong Kong Division of International Academy of Pathology. He is currently the regional editor for Australasia, Histopathology, overseas editor for Journal of the American Society of Cytopathology, outreach editor for Cytopathology, associate editor for Pathology, associate editor for Breast Cancer Research and Treatment, editorial advisory board member for Cancer Cytopathology, advisory board member for eBioMedicine and editorial board member for other journals including Acta Cytologica, Chinese Pathology Journal, Diagnostic Cytopathology, Human Pathology Case Reports, Journal of Pathology and Translational Medicine, Modern Pathology and Seminars in Diagnostic Pathology. Prof Tse has given many invited presentations, convened regional and international meetings and has published actively in breast pathology, and has published extensively.

Dr. Engels is Head of Cytopathology of the Institute of Pathology of the University Hospital Cologne, Germany since 2011.

Dr. Engels received her medical degree in Aachen / Germany in 1984. She completed training in internal medicine and in hematology/medical oncology and passed the International Board of Cytopathology Examination in 1999. She started to work in clinical cytology in 1992 and practiced cytology in the context of a busy hematology/oncology unit. 2009 she joined the Institute of Pathology of the University Hospital Bonn and changed to the University Hospital Cologne two years later.

Her main fields of interest include lung cytology and cytology of serous fluids. She is co-author of The International System for Serous Fluid Cytopathology and an expert member of the IAC-IARC-WHO Joint Editorial Board for the WHO Reporting System for Lung Cytopathology.

She’s member of the editorial boards of Acta Cytologica and Cytopathology and reviewer for several journals. She has been serving the German Society of Cytology as president and is now secretary general. She’s effective member of the EFCS (European Federation of Cytology Societies) and chair of the Educational Committee of the EFCS. She has received the 2021 Maurice Goldblatt Award of the IAC.

Dr. Engels has been teaching cytology since many years. She’s organizing an annual cytology tutorial in Cologne. She has given numerous lectures and workshops in Germany and abroad.

23.06.2023

Dr. Lozano graduated and obtained PhD in Medicine and Surgery from the University of Navarra. She specialized in Pathology at the University Clinic of Navarra (CUN). Dr. Lozano completed a postdoctoral stay at the University of Nebraska Medical Center, in the Department of Pathology and Microbiology (March 1993-April 1995). Currently, Dr. Lozano is director of the Department of Pathology of the Clínica Universidad de Navarra, Pamplona, and Head of cytopathology and molecular pathology in cytology. Dr. Lozano is Associate Professor of Pathology at Medical School of the University of Navarra. She is the Past President of the Spanish Society of Cytopathology, and the President-Elect of the Spanish Society of Pathology

Active member of SEAP (Sociedad Española de Anatomía Patológica), SEC (Sociedad Española de Citología), ESP (European Society of Pathology and Member of the Cytopathology Working group), ASC American Society of Cytopathology , IAC (International Academy of Cytology). Member of the expert panel for biomarker guidelines of the Spanish Societies of Pathology and Medical Oncology (SEOM).

Member of Editorial boards of Several journals

As researcher, Dr. Lozano is part of multidisciplinary teams within the university itself, as well as national and international levels. She has special dedication to lung and pancreas cytopathology as well as great interest and extensive experience in new approaches of FNAB and the development and application of molecular techniques in cytological samples and small samples by obtaining material using minimally invasive methods. She is deeply involved in the study of tumor microenvironment in lung and pancreatic tumors. She dedicates also to surgical pathology of Lung and Mediastinum.

Dr. Lozano has written more than 190 articles in national and international scientific journals. She has presented more than 400 communications to meetings, more than 200 lectures given, as well as several courses on FNA and molecular biology applied to cytopathology.